- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Vertex Pharmaceuticals (NASDAQ:VRTX), Quotes and News Summary
Vertex Pharmaceuticals (NASDAQ: VRTX)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-01 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.520 | 3.600 | 0.0800 | ||||
| REV | 2.130B | 2.196B | 66.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Vertex Pharmaceuticals Questions & Answers
You can purchase shares of Vertex Pharmaceuticals (NASDAQ: VRTX) through any online brokerage.
Other companies in Vertex Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
The latest price target for Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by HC Wainwright & Co. on Friday, August 5, 2022. The analyst firm set a price target for 300.00 expecting VRTX to rise to within 12 months (a possible 4.16% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $288.03 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Vertex Pharmaceuticals.
Vertex Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Vertex Pharmaceuticals.
Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.